Levels of illicit drug use in France in 2017
Tendances n° 128, OFDT, 6 p.
Based on the findings of the 2017 Health Barometer Survey of Santé publique France (data processed by OFDT) which interviewed over 20,000 people aged 18 to 64 years, this issue of Tendances describes the changes in illicit drug use and offers an overview of cannabis supply modes. Levels of use are presented according to the gender, age and professional activity.
In 2017, the proportion of cannabis lifetime users continued to increase in France, and now concerns nearly half of the adult population. While the proportion of current users in the adult population overall has not changed relative to 2014 (one in ten adults), growing regular use in the working population over 25 is becoming established, suggesting that cannabis use may no longer be exclusive to younger generations and could continue after entering the workforce.
In the same way as for cannabis, cocaine and MDMA/ecstasy use is observed, more frequently than before, outside the key age group of 18-25, reflecting the growing accessibility and availability of these substances.
Lifetime use of other illicit substances (other than MDMA/ecstasy and hallucinogenic mushrooms) remained similar in 2014 and 2017. Lifetime use of heroin or crack cocaine is still extremely rare in the overall adult population.
Authors : Stanislas Spilka, Jean-Baptiste Richard, Olivier Le Nézet, Eric Janssen, Alex Brissot, Antoine Philippon, Jalpa Shah, Sandra Chyderiotis, Raphaël Andler, Chloé Cogordan
Download the PDF file (591 Ko)
Drugs in Europe
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.